Premium
Response of the clinically uninvolved skin of psoriatic patients to repeated tape stripping during cyclosporin A treatment
Author(s) -
GERRITSEN M.J.P.,
RULO H.F.C.,
ARNOLD W.P.,
KERKHOF P. C. M.
Publication year - 1994
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.1994.tb02897.x
Subject(s) - psoriasis , medicine , dermatology , involucrin , immunohistochemistry , filaggrin , calcineurin , transplantation , keratinocyte , atopic dermatitis , in vitro , biology , biochemistry
Summary It is well established that cyclosporin A (CyA), a widely used immunosuppressant in human organ transplantation, is an effective drug in the treatment of psoriasis. Although it has been postulated that the effect of CyA in psoriasis is mediated through antilymphocyte activity, there is also evidence suggesting that CyA exerts a direct cytostatic effect on epidermal keratinocytes, but results of studies relating to the latter have been contradictory. Using immunohistochemical methods we investigated the influence of systemic CyA on proliferation and differentiation in the tape‐stripped uninvolved skin of psoriatic patients, a model which provides the opportunity of studying epidermal regeneration in the absence of a significant accumulation of T lymphocytes. We addressed the question of whether CyA (3–5 mg/kg/day) modulates epidermal proliferation and differentiation following standardized injury in uninvolved skin of psoriatic patients. Ten patients with severe psoriasis participated in this study. The dosages of CyA were sufficient to induce a marked and statistically significant improvement (PASI, week 0, 20.5·4.4; PASI, week 16, 4.3 ± 0.6). Before CyA treatment, and during week 16 of treatment, Sellotape stripping was carried out on a 2‐cm 2 area of the uninvolved skin of psoriatic patients. After 48 h punch biopsies were taken. Immunohistochemical assessment of recruitment of cycling cells (Ki‐67), filaggrin, involucrin, T lymphocytes and tenascin, was carried out. We did not find any significant alteration during the treatment period in the tape‐stripped uninvolved skin of psoriatic patients. We conclude that epidermal hyperproliferation and abnormal keratinization are not modulated directly by CyA at therapeutic doses in vivo. Furthermore, our study provides indirect evidence that the antipsoriatic effect of CyA is mediated by the immune system.